COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 176 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $3,000 | +200.0% | 2,100 | +90.9% | 0.00% | – |
| Q2 2019 | $1,000 | -96.0% | 1,100 | -26.7% | 0.00% | -100.0% |
| Q4 2018 | $25,000 | -3.8% | 1,500 | -58.3% | 0.00% | 0.0% |
| Q3 2018 | $26,000 | -38.1% | 3,600 | +56.5% | 0.00% | -33.3% |
| Q2 2018 | $42,000 | -77.0% | 2,300 | -81.6% | 0.00% | -80.0% |
| Q1 2018 | $183,000 | +76.0% | 12,500 | +4.2% | 0.02% | +400.0% |
| Q4 2017 | $104,000 | +3366.7% | 12,000 | +3900.0% | 0.00% | – |
| Q3 2017 | $3,000 | 0.0% | 300 | -89.7% | 0.00% | – |
| Q2 2017 | $3,000 | -88.9% | 2,900 | -69.8% | 0.00% | -100.0% |
| Q1 2017 | $27,000 | +50.0% | 9,600 | +585.7% | 0.00% | 0.0% |
| Q4 2016 | $18,000 | +260.0% | 1,400 | +55.6% | 0.00% | – |
| Q2 2016 | $5,000 | – | 900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rubric Capital Management LP | 1,926,283 | $40,105,000 | 3.74% |
| Camber Capital Management LP | 4,000,000 | $83,280,000 | 2.20% |
| FRAZIER MANAGEMENT LLC | 943,666 | $19,647,000 | 1.76% |
| MANGROVE PARTNERS IM, LLC | 593,741 | $12,362,000 | 1.56% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 303,685 | $6,323,000 | 1.07% |
| Eventide Asset Management | 2,427,976 | $50,550,000 | 0.99% |
| Avidity Partners Management LP | 1,000,400 | $20,828,000 | 0.97% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,108,219 | $23,073,000 | 0.93% |
| Perceptive Advisors | 2,058,068 | $42,849,000 | 0.63% |
| Rock Springs Capital Management LP | 1,175,000 | $24,464,000 | 0.62% |